Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_assertion type Assertion NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_head.
- NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_assertion description "[Two models of leukemia were used, one genetic (conditional alpha4 ablation of BCR-ABL1 [p210(+)] leukemia) and one pharmacological (anti-functional alpha4 antibody treatment of primary ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_provenance.
- NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_assertion evidence source_evidence_literature NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_provenance.
- NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_assertion SIO_000772 23319569 NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_provenance.
- NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_assertion wasDerivedFrom befree-20150227 NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_provenance.
- NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_assertion wasGeneratedBy ECO_0000203 NP219665.RAXsNAsSc2zRKilEB2dzQGUiSTH8kdNTVMIEzAEM21t1M130_provenance.